Ketone Ester for Metabolic Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a supplement called Ketone Ester (KE) to determine its potential to boost brain function and improve thinking skills. The focus is on individuals with metabolic syndrome, a condition that includes high blood pressure or high blood sugar, who have no memory or thinking problems. Participants will take either the KE supplement or a placebo (a harmless substance resembling the supplement) for 28 days to compare changes in brain energy use and thinking skills. Those with metabolic syndrome and no cognitive issues may find this trial suitable. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research on brain health and metabolic syndrome.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you cannot participate if you are taking metformin or following a ketogenic diet or taking other ketogenic supplements.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that ketone esters are generally safe for most people. In studies comparing different ketone supplements, participants typically did not report major side effects. Instead, they experienced benefits such as increased energy and improved focus. However, some individuals might experience mild stomach discomfort, a common reaction to new dietary supplements.
One study found that ketone esters can induce a state called ketosis, where the body uses ketones for energy instead of sugar, without causing harmful changes in blood fat levels. Research supports the safety of ketone esters.
Evidence also indicates that ketone esters can enhance athletic performance and mental clarity. Overall, existing research suggests that ketone esters are safe when taken as directed, though individual reactions may vary.12345Why are researchers excited about this trial?
Unlike standard treatments for metabolic syndrome, which often include lifestyle changes and medications like statins and antihypertensives, the Ketone Ester drink offers a unique approach by utilizing ketone esters as an active ingredient. Ketone esters provide an alternative energy source that can improve metabolic efficiency and potentially aid in weight management, a critical aspect of addressing metabolic syndrome. Researchers are excited about this treatment because it targets the metabolic pathways directly, potentially offering benefits in energy utilization and reduction of risk factors associated with metabolic syndrome.
What evidence suggests that Ketone Ester might be an effective treatment for metabolic syndrome?
Research has shown that ketone esters can provide the brain with an alternative energy source, especially when it cannot use glucose effectively. In this trial, one group of participants will receive the Ketone Ester drink, which studies have found might boost brain function by supplying a steady energy source. This is particularly important for conditions like Alzheimer's, where the brain struggles to use glucose. Early findings also suggest that ketone esters can help control blood sugar levels, benefiting those with metabolic issues. Although specific data on brain improvements in Alzheimer's is limited, the positive results in brain function and blood sugar management suggest potential benefits.12367
Who Is on the Research Team?
Dimitrios I Kapogiannis, M.D.
Principal Investigator
National Institute on Aging (NIA)
Are You a Good Fit for This Trial?
Adults aged 55 or older with metabolic syndrome but no cognitive impairment can join this study. They must be able to consent, take oral meds, and follow the study plan including MRI/MRS scans. Excluded are those with significant psychiatric conditions, certain infections, on metformin or non-English speakers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the study supplement or placebo for 28 days, with assessments at Visits 2, 3, and 4
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a follow-up visit to obtain DNA
What Are the Treatments Tested in This Trial?
Interventions
- HVMN Ketone Esther drink
- Ketone Ester drink
- Placebo: isocaloric dextrose drink
HVMN Ketone Esther drink is already approved in United States for the following indications:
- Research use for cognitive enhancement and Alzheimer's disease prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institute on Aging (NIA)
Lead Sponsor